The Canada respiratory devices market size is expected to register at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising number of respiratory disease patients.
Respiratory diseases affect the breathing organs and tissues of the individual by making gas exchange difficult. They directly affect the normal functioning of the respiratory tract including the trachea, alveoli, bronchi, pleurae, bronchioles, pleural cavity, and muscles of respiration. Respiratory diseases range from mild diseases such as common cold to the life-threatening disorders such as lung cancer. The most common types of respiratory diseases includes obstructive lung diseases, restrictive lung diseases, chronic respiratory diseases, respiratory tract infections, malignant tumors, pleural cavity diseases, pulmonary vascular diseases, and neonatal diseases. Therefore, the respiratory devices are most commonly use by the patients suffering from respiratory disorders.
The respiratory device, also known as as respirator, is designed to protect the wearer from inhaling hazardous atmospheric gases and particulate. The air-purifying respirator is used to obtain the respirable air by filtering a contaminated air in the atmosphere. On the other hand, the air-supplied respirators are used as alternatives for the supply of breathable air. Air-purifying respirators are inexpensive, disposable, and single-use face masks, also called gas mask. A wide range of industries use respirators including healthcare & pharmaceuticals, oil & gas industries, manufacturing industries, mining industry, cement production industries, textile industry, and defense & public safety services.
The COVID-19 pandemic has affected almost every industry including the healthcare industry. The high risk of developing serious illness due to coronavirus disease has made it challenging for several other healthcare problems for the patients having respiratory disorders. Therefore, the large scale manufacturing of critical care devices for the patients having respiratory disorders has fuel the expansion of the market during the pandemic situations. Furthermore, the outbreak of coronavirus disease has resulted in long-term association between healthcare and non-healthcare industries to manufacture respiratory care devices. This resulted into many opportunities for the expansion of respiratory devices market.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing hospitalization of middle-aged patients suffering from respiratory disorders to a significant number is anticipated to drive the market growth during the forecast period.
- Growing technological advancements to meet the demand for home care respiratory devices is expected to boost the market expansion during the projected period.
- Rising development of portable devices such as home sleep monitor, which incorporates oximetry and respiratory tests, is anticipated to spur the market growth in the coming years.
- Unfavorable reimbursement, large number of under diagnosed patients, and lack of awareness is expected to hamper the growth of market during the forecast period.
- Increasing government funding and rising demand for affordable home care therapeutic devices is anticipated to create the opportunities for the market in the coming years.
Scope of the Report
The report on the Canada respiratory devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Respiratory Devices Market - Canada Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Diagnostic and Monitoring Devices (Capnographs, Pulse Oximeters, Spirometers, Peak Flow Meters, Sleep Test Devices, and Others), Therapeutic Devices (Nebulizers, CPAP Devices, Inhalers, Oxygen Concentrators, Humidifiers, Ventilators, BiPAP Devices, and Others), and Disposables (Breathing Circuit, Masks, and Others)
|
|
Country
|
Canada
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Masimo Corporation; Medtronic plc; ResMed Inc.; Philips Healthcare; and GE Healthcare
|
Canada Respiratory Devices Market Segment Insights
Spirometer segment is projected to hold a major market share
Based on diagnostic and monitoring devices, the market is fragmented into capnographs, pulse oximeters, spirometers, peak flow meters, sleep test devices, and others. The spirometer segment is projected to hold a major market share during the projected period due to increasing prevalence of chronic respiratory diseases among adults and children along with the rising demand for digital spirometers in the country. On the other hand, the oximeters segment is anticipated to grow at a rapid pace during the projected period owing to the growing technological advancements for the development of upgraded oximeters.
Inhalers segment is expected to expand at a significant CAGR
On the basis of therapeutic devices, the Canada respiratory devices market is segregated into nebulizers, CPAP devices, inhalers, oxygen concentrators, humidifiers, ventilators, BiPAP devices, and others. The inhalers segment is expected to expand at a significant CAGR during the forecast period owing to the increasing number of asthmatic patients in the country. Moreover, wide range use of inhalers in the treatment of major respiratory ailments is expected to promote the expansion of the market segment in the coming years. On the other hand, the ventilators segment is expected to boost the growth of the market segment during the forecast period due to increasing hospitalization of cardiovascular respiratory disease patients along with surge in demand for personal protection equipment and ventilators in the country.
Breathing circuit segment is anticipated to constitute a major market share
In terms of disposables, the market is classified into breathing circuit, masks, and others. The breathing circuit segment is anticipated to constitute a major market share during the forecast period owing to increase in the number of respiratory surgeries, anesthesia usage, and powerful regulatory functions of the breathing circuit bags. Furthermore, the rising demand for complex procedures and advanced techniques is expected to grow the market segment at a robust rate during the projected period. However, the masks segment is projected to grow at a considerable rate due to growing awareness, increasing industrialization, and rising pollution levels in the country.
Segments
Segments Covered in the Report
The Canada respiratory devices market is segmented on the basis of:
Diagnostic and Monitoring Devices
- Capnographs
- Pulse Oximeters
- Spirometers
- Peak Flow Meters
- Sleep Test Devices
- Others
Therapeutic Devices
- Nebulizers
- CPAP Devices
- Inhalers
- Oxygen Concentrators
- Humidifiers
- Ventilators
- BiPAP Devices
- Others
Disposables
- Breathing Circuit
- Masks
- Others
Country
Key Players
- Masimo Corporation
- Medtronic plc
- ResMed Inc.
- Philips Healthcare
- GE Healthcare
Competitive Landscape
The key players competing in the Canada respiratory devices market are Masimo Corporation; Medtronic plc; ResMed Inc.; Philips Healthcare; and GE Healthcare. The Companies are engaging in vigorous acquisitions, collaborations, and ventures to consolidate their position in the market.
Request For Customization
Enquiry Before Buying
Speak With Analyst
